Contraline is a Series b-stage Biotechnology Research company based in Charlottesville, Virginia, United States with roughly 11-50 employees. Contraline's team spans 4 in engineering, 3 in operations and 1 in sales. Contraline is led by Kevin Eisenfrats, Co-Founder and CEO, alongside Alex Pastuszak, MD, PhD (Chief Medical Officer), Justin Mattice (Chief Commercial Officer), Yelena Tropsha, PhD (Chief Technology Officer), James P. Tursi, M.D. (Chief Scientific Officer), Robert S. Goldman (Vice President / Global Head of Clinical Operations) and Robert Greenleaf (VP of Quality and Operations).

Kevin Eisenfrats is the CEO of Contraline, serving as Co-Founder and CEO. Kevin Eisenfrats leads the company and its executive team.

Contraline's leadership team is led by Kevin Eisenfrats (Co-Founder and CEO) and includes Alex Pastuszak, MD, PhD (Chief Medical Officer), Justin Mattice (Chief Commercial Officer), Yelena Tropsha, PhD (Chief Technology Officer), James P. Tursi, M.D. (Chief Scientific Officer), Robert S. Goldman (Vice President / Global Head of Clinical Operations), Robert Greenleaf (VP of Quality and Operations). Each runs a function within the company.

Contraline's team spans 4 in engineering, 3 in operations and 1 in sales. Each department reports up to the leadership team, as shown in the org chart above.

Contraline's engineering team has 4 people, making it the largest team at Contraline.

Contraline's operations team has 3 people, making it the second-largest team at Contraline.

Contraline's sales team has 1 person, making it the third-largest team at Contraline.

Contraline has 18 employees, of which 4 work in engineering, 3 in operations and 1 in sales.

Contraline is headquartered in Charlottesville, Virginia, United States.

Contraline is a Series b-stage company operating in Biotechnology Research.

To correct or remove a profile from Contraline's page, email info@insideorg.com with the name and page link. Verified requests are processed within a few business days.